Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (1) , 5289-5304
Abstract
Bladder cancer (BLCA), originating from the epithelium of the urinary bladder, was the second most common malignancy in the urinary system with a high metastasis rate and poor post-metastasis prognosis. Alternative splicing events (ASEs) were regarded as important markers of tumor progression and prognosis, however, their roles in bladder cancer bone metastasis have not been recognized. In this study, we constructed a predictive model based on ASEs and explored the molecular mechanism of ASEs in BLCA bone metastasis, based on data from the Cancer Genome Atlas (TCGA) and TCGASpliceSeq databases. We proposed the hypothesis that the splicing events of ITGB4 was regulated by the splicing factor JUP, and this regulation might play a key role in BLCA bone metastasis through the glycosphingolipid biosynthesis ganglio series pathway.Keywords
All Related Versions
Funding Information
- The National Natural Science Foundation of China
- National Natural Science Foundation of China (Grant No. 81772856)
- Youth Fund of Shanghai Municipal Health Planning Commission (No.2017YQ054)
This publication has 58 references indexed in Scilit:
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival AnalysisPLOS ONE, 2013
- Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivoBreast Cancer Research, 2012
- Role of β4 integrin phosphorylation in human invasive squamous cell carcinoma: regulation of hemidesmosome stability modulates cell migrationLaboratory Investigation, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Alternative isoform regulation in human tissue transcriptomesNature, 2008
- Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic markerCarcinogenesis, 2008
- Targeting integrin β4 for cancer and anti-angiogenic therapyTrends in Pharmacological Sciences, 2007
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- Compartmentalization of integrin α6β4 signaling in lipid raftsJournal of Cell Biology, 2003
- IntegrinsCell, 2002